Iraqi Board Dermatology common mistakes
Iraqi Board Dermatology · Understand the traps and how to avoid them.
When shown a histology description or slide-based vignette, candidates commit to a single diagnosis from the dominant pattern (e.g., 'spongiotic dermatitis') and stop, without listing the features that discriminate the specific entities in that pattern group (psoriasiform, interface, vesiculobullous, granulomatous).
Dermatopathology teaching rewards pattern recognition, so candidates memorize one 'classic' picture per disease and never build the differential-with-discriminators habit. Under exam pressure the first match feels like the answer, and the question is usually built to punish exactly that shortcut.
What to do instead
For every pattern group, write a one-page discriminator table: for spongiotic dermatitis list the features separating allergic contact, nummular, dyshidrotic, seborrheic, atopic, and drug-related; for interface dermatitis separate lichen planus, lichenoid drug eruption, lupus, and erythema multiforme. Drill by covering the diagnosis and stating two findings that rule alternatives out.
Candidates describe lesions in vague nouns ('rash', 'lesion', 'spot') and skip the primary lesion, arrangement, distribution, and mucosal/nail/palmoplantar involvement, then answer a question whose correct option hinges on precisely those descriptors.
Clinical trainees are used to seeing the patient and recognizing the disease visually; the verbal morphology vocabulary is learned passively and never rehearsed aloud. Exam vignettes deliberately encode the diagnosis in the description, so a candidate who reads for the 'feel' of the case misses the decisive word.
What to do instead
Adopt a fixed descriptive order for every vignette: primary lesion, colour, size, border, surface, arrangement (annular, linear, grouped, reticulate), distribution (acral, flexural, photo-exposed, dermatomal), then secondary changes and mucosal/nail/palmoplantar status. Practice on 20 vignettes by writing the description before reading the options.
For a child with a rash, candidates apply the adult differential and adult dosing, missing age-specific diagnoses (neonatal lupus, Langerhans cell histiocytosis, incontinentia pigmenti, Kawasaki disease, staphylococcal scalded skin syndrome) and the fact that some adult diseases essentially do not occur in infancy.
Pediatric dermatology is a small fraction of adult training, and the 'common things are common' heuristic is calibrated to adults. Candidates also under-weight birth history, developmental milestones, and family history, which are the discriminators in genodermatoses.
What to do instead
Build an age-stratified differential: first 4 weeks, infancy, toddler, school age, adolescence. For each age band memorize the five diagnoses that must not be missed. Rehearse the red-flag set (fever plus rash, blistering in a neonate, purpura, mucosal involvement) until it is automatic.
Candidates answer therapeutic questions by naming the first-line drug but omit the pre-treatment workup, monitoring schedule, and the specific adverse effect the question is testing (e.g., methotrexate and liver fibrosis risk factors, cyclosporine and blood pressure/creatinine, dapsone and G6PD, isotretinoin and pregnancy prevention, biologics and tuberculosis screening).
Therapy is studied as a list of indications rather than as a package of contraindications, baseline tests, and monitoring. Exam writers test the safety envelope because that is where real-world harm occurs.
What to do instead
For each systemic agent write a four-column card: indication, baseline tests, monitoring interval, and the three adverse effects most likely to be examined. Include drug interactions and pregnancy category. Review the cards weekly rather than re-reading textbook chapters.
When a vignette describes a blistering eruption, candidates pick the diagnosis from the clinical picture alone and ignore the immunopathology discriminators (direct immunofluorescence pattern, split level on salt-split skin, desmoglein 1 versus 3 profile), so they choose pemphigus where the correct answer is bullous pemphigoid or epidermolysis bullosa acquisita.
The clinical descriptions overlap heavily (tense versus flaccid bullae is a single word in a long stem), and immunofluorescence is treated as an optional extra rather than the deciding evidence. Candidates also confuse the meaning of intercellular versus linear basement membrane zone staining.
What to do instead
Memorize a matrix of disease versus DIF pattern, split level, target antigen, and mucosal involvement. Then work backwards: given a DIF result, state the diagnosis and the expected clinical finding. Test yourself in both directions until the mapping is bidirectional.
Candidates manage pigmentary and hair/nail disorders as cosmetic afterthoughts, missing systemic associations and the specific examination manoeuvres (Wood lamp accentuation, hair pull test, trichoscopy features, nail fold capillary changes, the difference between anagen effluvium and telogen effluvium, longitudinal melanonychia warning signs).
These domains are perceived as low-yield and are studied last, so only superficial facts are retained. Yet they contain high-discrimination questions because the findings are precise and unambiguous.
What to do instead
Learn each domain through its examination sequence rather than its disease list: for hair, the pull test, shed-hair count, and scalp dermatoscopy; for nails, the dermoscopic signs of subungual melanoma and the nail fold findings in connective tissue disease. Attach one systemic association to every pigmentary disorder you memorize.
Candidates treat cutaneous infections as a single 'give an antibiotic/antifungal' category, failing to link organism to the correct diagnostic test and therapy (KOH versus culture versus PCR, scabies microscopy versus dermoscopy, atypical mycobacteria requiring culture at different temperatures, HSV PCR versus Tzanck smear, syphilis serology algorithms and the timing of dark-ground examination).
Microbiology is studied as a separate subject and never integrated with clinical dermatology, so the candidate knows the organism name but not the specimen, transport, or test that confirms it. Sexually transmitted infection questions additionally require staging and partner management, which are skipped.
What to do instead
Build an organism-to-test-to-drug table covering bacteria, mycobacteria, fungi, viruses, and parasites, including specimen type and time to result. For syphilis, learn the stage-by-stage serology and the interpretation of non-treponemal titres. Rehearse one clinical vignette per organism.
Candidates answer tumor questions by naming the diagnosis but skip the management-relevant variables: margin adequacy, depth measurement (Breslow), mitotic rate, ulceration, perineural or lymphovascular invasion, and the resulting staging and surgical margins. They also fail to distinguish premalignant from malignant and to apply the criteria that separate benign from malignant melanocytic lesions.
Tumor pathology is memorized as a list of names and histologic descriptions. Staging systems and margin guidelines are perceived as surgical trivia, yet they generate a large share of oncology questions and are the part most likely to change with guideline updates.
What to do instead
For each major tumor, write the report elements a dermatopathologist must include and the management decision each element drives. Practice staging melanoma and squamous cell carcinoma from raw data, and learn the dermoscopic and histologic criteria that justify excision of a doubtful melanocytic lesion.
Candidates read a drug eruption or systemic-disease vignette and answer the dermatologic diagnosis without connecting it to the underlying internal disease, the culprit drug's class and timing, or the severity category that dictates withdrawal and admission (e.g., separating maculopapular exanthem from DRESS, Stevens-Johnson syndrome/toxic epidermal necrolysis, and acute generalized exanthematous pustulosis by latency, organ involvement, and mucosal findings).
Dermatology and internal medicine are revised in separate blocks, so the candidate never practises the cross-link. Severe cutaneous adverse reactions are also confused because they share fever and rash and differ mainly in timing and systemic features.
What to do instead
Create a comparison table for severe cutaneous adverse reactions with columns for latency, mucosal involvement, organ involvement, eosinophilia, pustulation, and mortality. For each systemic disease (diabetes, thyroid, inflammatory bowel disease, malignancy, HIV) list its cutaneous markers and the sign that should trigger a systemic workup.
Candidates answer procedure and therapy questions by choosing the most powerful option rather than the correctly sequenced one, ignoring contraindications, consent, anaesthetic maximum doses, laser wavelength-tissue target matching, and the aftercare or complication that the question is really asking about. In research and ethics items they accept a conclusion from a small uncontrolled series or misapply consent and confidentiality rules.
Procedural and ethical content is treated as background reading because it feels intuitive. In reality these questions test explicit numeric limits and formal principles that intuition gets wrong, and candidates rarely rehearse them.
What to do instead
Memorize the numeric safety limits (maximum lidocaine dose with and without adrenaline, laser parameters by target chromophore, suture removal timing by site) and the sequence of a consent discussion. For evidence questions, practise appraising study design, bias, and level of evidence on short abstracts, and learn the four principles of biomedical ethics with one dermatology example each.